Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Aquat Toxicol ; 96(1): 53-61, 2010 Jan 21.
Article in English | MEDLINE | ID: mdl-19850364

ABSTRACT

To establish a novel in vivo test system for rapid detection of environmental estrogens, an ere-zvtg1: gfp transgenic zebrafish line has been generated. In this transgenic line, under control conditions, GFP was exclusively expressed in the liver of mature adult female fish. Male and larval transgenic fish did not express GFP but could be induced to express GFP in the liver after exposure to 17-alpha-ethynylestradiol (EE(2)). Concurrent accumulation of zvtg1 and gfp mRNAs in embryos and larvae after EE(2) exposure was observed, which indicated that the expression of gfp transgene was driven by the zvtg1 promoter. Green fluorescence was first observed in the liver at 53, 74, 100 or 131h post-fertilization (hpf) after exposure to 100, 10, 1 or 0.1ng/L EE(2) from 1 to 2 cell stage, respectively. As for mature male transgenic zebrafish, green fluorescence was observed after exposure to 100, 10, 1 or 0.1ng/L EE(2) for 2, 3, 4 or 7 days, respectively; as for mature female, fluorescence was increased after exposure to relatively high concentrations of EE(2) (10 and 100ng/L). Green fluorescence in the liver was increased with prolonging of exposure time and was repeatedly induced after removal and re-addition of EE(2). We also demonstrated that GFP expression could be induced by other estrogenic compounds, including beta-estradiol (E(2), 0.1microg/L), cadmium chloride (CdCl(2), 10microg/L), zearalenone (50microg/L), estriol (E(3), 1microg/L), diethylstilbestrol (DES, 50ng/L) bisphenol A (BPA, 1mg/L) but not by weakly estrogenic compounds such as nonylphenol (NP, up to 10mg/L), or non-estrogenic steroid hormones such as progesterone (up to 100mg/L) and 17-hydroxysteroid (up to 50mg/L). These data suggest the transgenic zebrafish is sensitive and specific for detection of estrogenic compounds. Because the observed-effect concentrations are as low as those of environment and the observed-effect exposure times are very short, this transgenic fish is a promising candidate system for monitoring environmental estrogens directly, rapidly and easily.


Subject(s)
Environmental Monitoring/methods , Ethinyl Estradiol/analysis , Green Fluorescent Proteins/metabolism , Water Pollutants, Chemical/analysis , Zebrafish/genetics , Zebrafish/metabolism , Animals , Animals, Genetically Modified , Base Sequence , Embryo, Nonmammalian , Endocrine Disruptors/pharmacology , Estrogens , Ethinyl Estradiol/pharmacology , Female , Gene Expression Regulation/drug effects , Green Fluorescent Proteins/genetics , Larva , Liver/metabolism , Male , Molecular Sequence Data , Sensitivity and Specificity , Vitellogenins/genetics , Water Pollutants, Chemical/pharmacology , Zebrafish Proteins/genetics
2.
Biochem Biophys Res Commun ; 371(2): 185-90, 2008 Jun 27.
Article in English | MEDLINE | ID: mdl-18395006

ABSTRACT

Rehmannia glutinosa, a Traditional Chinese Medicine (TCM), has been used to increase physical strength. Here, we report that Rehmannia glutinosa extract (RE) inhibits adipocyte differentiation and adipogenesis. RE impairs differentiation of 3T3-L1 preadipocytes in a dose-dependent manner. At the molecular level, treatment with RE inhibits expression of the key adipocyte differentiation regulator C/EBPbeta, as well as C/EBPalpha and the terminal marker protein 422/aP2, during differentiation of preadipocytes into adipocytes. Additionally, RE inhibits the mitotic clonal expansion (MCE) process of adipocyte differentiation, and RE prevents localization of C/EBPbeta to the centromeres. RE also prevents high fat diet (HFD) induced weight gain and adiposity in rats. Taken together, our results indicate that Rehmannia glutinosa extract inhibits preadipocyte differentiation and adipogenesis in cultured cells and in rodent models of obesity.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , CCAAT-Enhancer-Binding Protein-alpha/antagonists & inhibitors , CCAAT-Enhancer-Binding Protein-beta/antagonists & inhibitors , Obesity/prevention & control , Plant Extracts/pharmacology , 3T3-L1 Cells , Adipocytes/metabolism , Adipogenesis/genetics , Animals , CCAAT-Enhancer-Binding Protein-alpha/analysis , CCAAT-Enhancer-Binding Protein-alpha/metabolism , CCAAT-Enhancer-Binding Protein-beta/analysis , CCAAT-Enhancer-Binding Protein-beta/metabolism , Centromere/chemistry , Centromere/metabolism , Diet , Disease Models, Animal , Fats/administration & dosage , Fats/adverse effects , Fatty Acid-Binding Proteins/antagonists & inhibitors , Fatty Acid-Binding Proteins/metabolism , Male , Mice , Mitosis/drug effects , Obesity/chemically induced , Obesity/metabolism , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...